NCT02668003

Brief Summary

It is known from many studies that when patients have developed chronic widespread pain (CWP) or fibromyalgia that managing such symptoms is extremely challenging for both doctors and patients. The investigators have shown in a recently completed study funded by Arthritis Research UK that a course of Cognitive Behaviour Therapy delivered by telephone (tCBT) or an exercise regime can substantially improve the chances of the symptoms improving. The investigators now plan to offer this therapy to patients who are at a high risk of developing CWP (but who have not developed it yet) to see whether its onset can be prevented.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,002

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2016

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 20, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 29, 2016

Completed
3 months until next milestone

Study Start

First participant enrolled

May 1, 2016

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2019

Completed
2.2 years until next milestone

Results Posted

Study results publicly available

August 10, 2021

Completed
Last Updated

August 10, 2021

Status Verified

July 1, 2021

Enrollment Period

3.1 years

First QC Date

January 20, 2016

Results QC Date

June 1, 2021

Last Update Submit

July 15, 2021

Conditions

Keywords

Prevention trialCognitive Behaviour TherapyCWPChronic widespread painRCTFibromyalgiaPrevention

Outcome Measures

Primary Outcomes (1)

  • Development of Chronic Widespread Pain Assessed by Questionnaire

    The development of new chronic widespread pain, as defined by ACR 1990 criteria for fibromyalgia and assessed by questionnaire, at follow-up will be compared between participants in the two treatment arms. A participant was counted as having chronic widespread pain if they said they had pain in the last month that had lasted a day or more, indicated on a paper manikin that the pain that was on both the left and right hand sides, and above and below the waist, and in the axial skeleton, and answered that they had this pain for more than 3 months. If they did not have pain that was that above and below the waist and on the left and right hand sides, and in the axial skeleton, or they did not say they had the pain for more than 3 months, then they did not have chronic widespread pain.

    12 months after treatment start

Secondary Outcomes (30)

  • Pain Assessed by Questionnaire

    3 months after treatment start

  • Pain Assessed by Questionnaire

    12 months after treatment start

  • Pain Assessed by Questionnaire

    24 months after treatment start

  • Illness Behaviour Assessed by Illness Behaviour Scale

    3 months after treatment start

  • Illness Behaviour Assessed by Illness Behaviour Scale

    12 months after treatment start

  • +25 more secondary outcomes

Study Arms (2)

Cognitive Behavioural Therapy

EXPERIMENTAL

Brief Cognitive Behavioural Therapy delivered by telephone

Behavioral: Cognitive Behavioural Therapy

Treatment as usual

NO INTERVENTION

The group allocated to usual care will receive no additional intervention - this will reflect the fact there is no specific intervention provided to patients currently for the prevention of CWP. Participants in this group will receive usual care and there will be no restriction on what this can involve. CBT is not readily available within the NHS and is generally restricted to persons who have developed specific conditions rather than persons at risk of those conditions.

Interventions

The CBT intervention, delivered by telephone, will consist of an initial assessment, 6 weekly sessions, and then booster sessions at 3 and 6 months. The intervention will be delivered by trained and accredited therapists. Participants will be supported by a self-management CBT manual. There will be a patient-centred assessment by the therapist for problem identification, risk assessment and development of a shared formulation of the current health problem. The sessions will involve education about musculoskeletal pain, somatic symptoms and specific CBT techniques such as pacing of activity, behavioural activation, diary keeping, identifying and challenging negative and unhelpful thinking patterns and the development of a longer term management plan.

Also known as: Telephone-delivered Cognitive Behavioural Therapy
Cognitive Behavioural Therapy

Eligibility Criteria

Age25 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A 'high-risk' profile for developing CWP as identified on the screening survey, i.e.:
  • Have pain for which the patient has sought consultation to primary care in the last 6 months
  • Any 2 of the following: Illness Behaviour Score \> 4; Somatic Symptom Score \> 2; Sleep Problem Score \> 4
  • Access to a land-line telephone or mobile telephone
  • Ability to understand English sufficiently to participate in the intervention
  • Ability to give informed consent
  • Aged 25 years or over

You may not qualify if:

  • Meeting American College of Rheumatology definition of CWP in the 1990 criteria for fibromyalgia (as assessed by the screening questionnaire)
  • Medical conditions which would make the proposed intervention unsuitable (e.g. cognitive ability)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

NHS Grampian

Aberdeen, United Kingdom

Location

NHS Greater Glasgow & Clyde

Glasgow, United Kingdom

Location

NHS Highland

Inverness, United Kingdom

Location

Related Publications (3)

  • Macfarlane GJ, Beasley M, Scott N, Chong H, McNamee P, McBeth J, Basu N, Hannaford PC, Jones GT, Keeley P, Prescott GJ, Lovell K. Maintaining musculoskeletal health using a behavioural therapy approach: a population-based randomised controlled trial (the MAmMOTH Study). Ann Rheum Dis. 2021 Jul;80(7):903-911. doi: 10.1136/annrheumdis-2020-219091. Epub 2021 Feb 1.

  • Fraser C, Beasley M, Macfarlane G, Lovell K. Telephone cognitive behavioural therapy to prevent the development of chronic widespread pain: a qualitative study of patient perspectives and treatment acceptability. BMC Musculoskelet Disord. 2019 May 10;20(1):198. doi: 10.1186/s12891-019-2584-2.

  • Macfarlane GJ, Beasley M, Prescott G, McNamee P, Keeley P, Artus M, McBeth J, Hannaford P, Jones GT, Basu N, Norrie J, Lovell K. The Maintaining Musculoskeletal Health (MAmMOTH) Study: Protocol for a randomised trial of cognitive behavioural therapy versus usual care for the prevention of chronic widespread pain. BMC Musculoskelet Disord. 2016 Apr 26;17:179. doi: 10.1186/s12891-016-1037-4.

MeSH Terms

Conditions

Chronic PainFibromyalgia

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMuscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Results Point of Contact

Title
Professor Gary Macfarlane
Organization
University of Aberdeen

Study Officials

  • Gary J Macfarlane, MBChB PhD MD

    University of Aberdeen

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 20, 2016

First Posted

January 29, 2016

Study Start

May 1, 2016

Primary Completion

June 1, 2019

Study Completion

June 1, 2019

Last Updated

August 10, 2021

Results First Posted

August 10, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

After completion of the study individual participant data will be made available to other researchers on request as decided by the study data management committee.

Locations